0001144204-17-021382.txt : 20170420
0001144204-17-021382.hdr.sgml : 20170420
20170420211635
ACCESSION NUMBER: 0001144204-17-021382
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170419
FILED AS OF DATE: 20170420
DATE AS OF CHANGE: 20170420
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PLx Pharma Inc.
CENTRAL INDEX KEY: 0001497504
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271707962
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8285 EL RIO STREET
STREET 2: SUITE 130
CITY: HOUSTON
STATE: TX
ZIP: 77054
BUSINESS PHONE: (713) 842-1249
MAIL ADDRESS:
STREET 1: 8285 EL RIO STREET
STREET 2: SUITE 130
CITY: HOUSTON
STATE: TX
ZIP: 77054
FORMER COMPANY:
FORMER CONFORMED NAME: Dipexium Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20140313
FORMER COMPANY:
FORMER CONFORMED NAME: Dipexium Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20100726
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: JORDEN DAVID EMERSON
CENTRAL INDEX KEY: 0001313516
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36351
FILM NUMBER: 17774029
MAIL ADDRESS:
STREET 1: 2635 TECHNOLOGY FOREST BLVD.
CITY: THE WOODLANDS
STATE: TX
ZIP: 77381
4
1
v464780_4.xml
OWNERSHIP DOCUMENT
X0306
4
2017-04-19
0
0001497504
PLx Pharma Inc.
PLXP
0001313516
JORDEN DAVID EMERSON
8285 EL RIO STREET,
SUITE 130
HOUSTON
TX
77054
0
1
0
0
Acting Chief Financial Officer
Common Stock
2017-04-19
4
A
0
119186
A
119186
D
Options
12.44
2017-04-19
4
A
0
33753
0
A
2017-04-19
2025-07-22
Common Stock
33753
33753
D
Received in exchange for 151,336 shares of common stock of PLx Opco Inc. (formerly PLx Pharma Inc.) in connection with the merger (the "Merger") of PLx Opco Inc. with a wholly owned subsidiary of PLx Pharma Inc. (formerly Dipexium Pharmaceuticals, Inc.).
Received in connection with the Merger in exchange for an employee stock option to buy 42,857 shares of PLx Opco Inc. common stock for $9.80 per share.
/s/ David E. Jorden
2017-04-20